JPH09505573A - スクラルファートと抗菌剤／イオン交換樹脂の複合体とからなる組成物 - Google Patents
スクラルファートと抗菌剤／イオン交換樹脂の複合体とからなる組成物Info
- Publication number
- JPH09505573A JPH09505573A JP7514807A JP51480795A JPH09505573A JP H09505573 A JPH09505573 A JP H09505573A JP 7514807 A JP7514807 A JP 7514807A JP 51480795 A JP51480795 A JP 51480795A JP H09505573 A JPH09505573 A JP H09505573A
- Authority
- JP
- Japan
- Prior art keywords
- ion exchange
- drug
- antibacterial agent
- exchange resin
- helicobacter pylori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9324409.3 | 1993-11-27 | ||
| GB939324409A GB9324409D0 (en) | 1993-11-27 | 1993-11-27 | Novel composition |
| PCT/EP1994/003803 WO1995014483A1 (fr) | 1993-11-27 | 1994-11-16 | Composition comprenant du sulcralfate ainsi qu'un complexe forme par un agent antimicrobien et une resine echangeuse d'ions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH09505573A true JPH09505573A (ja) | 1997-06-03 |
Family
ID=10745801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7514807A Pending JPH09505573A (ja) | 1993-11-27 | 1994-11-16 | スクラルファートと抗菌剤／イオン交換樹脂の複合体とからなる組成物 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0730464A1 (fr) |
| JP (1) | JPH09505573A (fr) |
| AU (1) | AU1065395A (fr) |
| GB (1) | GB9324409D0 (fr) |
| WO (1) | WO1995014483A1 (fr) |
| ZA (1) | ZA949377B (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007536249A (ja) * | 2004-05-03 | 2007-12-13 | イリプサ， インコーポレイテッド | 消化器官管腔集中性ホスホリパーゼ阻害薬 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595977A (en) * | 1993-10-27 | 1997-01-21 | Dumex-Alpharma A/S | Salts of amino glycosides |
| FR2956322A1 (fr) | 2010-02-17 | 2011-08-19 | Urgo Lab | Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie. |
| CN113274404A (zh) * | 2020-06-28 | 2021-08-20 | 天翊生物医药科技(天津)有限公司 | 医用吸附树脂的新用途及幽门螺杆菌消除药物 |
| CN116098863B (zh) * | 2023-03-20 | 2023-08-29 | 广东逸舒制药股份有限公司 | 一种硫糖铝口服混悬液及其制备方法 |
| CN118576724B (zh) * | 2024-05-28 | 2025-08-29 | 中国药科大学 | 一种针对胞内幽门螺杆菌的驱动型口服纳米制剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR7759M (fr) * | 1967-10-31 | 1970-03-16 | ||
| US4252790A (en) * | 1974-10-23 | 1981-02-24 | Interx Research Corporation | Method for treating gastric ulcer-prone patients |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
| EP0403048A3 (fr) * | 1989-06-14 | 1991-01-30 | Warner-Lambert Company | Un modèle de structure de système craniomandibulaire humain |
| GB9108080D0 (en) * | 1991-04-15 | 1991-06-05 | Smithkline Beecham Plc | Pharmaceutical composition |
| GB9211148D0 (en) * | 1992-05-26 | 1992-07-08 | Smithkline Beecham Plc | Novel treatment |
-
1993
- 1993-11-27 GB GB939324409A patent/GB9324409D0/en active Pending
-
1994
- 1994-11-16 EP EP95901388A patent/EP0730464A1/fr not_active Withdrawn
- 1994-11-16 AU AU10653/95A patent/AU1065395A/en not_active Abandoned
- 1994-11-16 JP JP7514807A patent/JPH09505573A/ja active Pending
- 1994-11-16 WO PCT/EP1994/003803 patent/WO1995014483A1/fr not_active Ceased
- 1994-11-25 ZA ZA949377A patent/ZA949377B/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007536249A (ja) * | 2004-05-03 | 2007-12-13 | イリプサ， インコーポレイテッド | 消化器官管腔集中性ホスホリパーゼ阻害薬 |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA949377B (en) | 1995-11-06 |
| GB9324409D0 (en) | 1994-01-12 |
| AU1065395A (en) | 1995-06-13 |
| EP0730464A1 (fr) | 1996-09-11 |
| WO1995014483A1 (fr) | 1995-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002316020B2 (en) | Pharmaceutical formulation comprising a proton pump inhibitor and antacids | |
| EP1194153B1 (fr) | Formulations pharmaceutiques liquides au gout masque. | |
| JP2635407B2 (ja) | 医薬咀しゃく錠組成物 | |
| US20070092553A1 (en) | Compositions and methods of making rapidly dissolving lonically masked formulations | |
| CA2531564C (fr) | Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe | |
| EP1086701B1 (fr) | Composition laxative contenant de la siméthicone | |
| MXPA03008057A (es) | Composiciones farmaceuticas con sabor oculto. | |
| JP2002534374A (ja) | 多粒子経口用量形態 | |
| AU2002316020A1 (en) | Pharmaceutical formulation comprising a proton pump inhibitor and antacids | |
| EP0922461A1 (fr) | Remedes contre l'hyperphosphatemie | |
| RU2671400C2 (ru) | Фармацевтические композиции для лечения от helicobacter pylori | |
| FR2832635A1 (fr) | Composition a base de cefuroxime axetil et son utilisation | |
| CA2765635A1 (fr) | Composition pharmaceutique de duloxetine ou ses sels pharmaceutiquement acceptables | |
| WO2004087111A1 (fr) | Compositions pharmaceutiques orales a gout masque | |
| EP0804168A1 (fr) | Composition au gout dissimule contenant un complexe medicament/polymere | |
| EP0642340A1 (fr) | Compositions a base d'inhibiteurs de recepteur h 2? a l'histamine et de complexes echangeurs cationiques | |
| Khan | Therapeutic applications of ion exchange resins | |
| US20060204585A1 (en) | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them | |
| JPH09505573A (ja) | スクラルファートと抗菌剤／イオン交換樹脂の複合体とからなる組成物 | |
| EP0261693A1 (fr) | Régulateur de lipides traité | |
| CN1652750A (zh) | 红霉素a及其衍生物的味道掩蔽组合物 | |
| JPH09501680A (ja) | Ｈ▲下２▼−アンタゴニストの経口組成物 | |
| US8865219B2 (en) | Orodispersible tablets of bitter active principles | |
| US20130115253A1 (en) | Sustained Release Suspension Preparation For Dextromethorphan | |
| JPWO1995033469A1 (ja) | 固形制酸剤及びその製造法 |